EDGAR Filing Documents for 0001176256-15-000293

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001176256-15-000293

Filing Date

2015-08-24

Accepted

2015-08-24 17:27:20

Documents

Period of Report

2015-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	REPORT OF FOREIGN ISSUER FOR THE PERIOD ENDED JUNE 30, 2015	nymox6kq2fs.htm	6-K	5667
2	QUARTERLY REPORT FOR THE QUARTER ENDED JUNE 30, 2015	exhibit99-1.htm	EX-99.1	424724
3	CEO CERTIFICATIONS	exhibit99-2.htm	EX-99.2	6859
4	CFO CERTIFICATIONS	exhibit99-3.htm	EX-99.3	6793
5		exhibit99-1x1x1.jpg	GRAPHIC	6096
	Complete submission text file	0001176256-15-000293.txt		453609

Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2

Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 1-800-936-9669

NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 151071701
SIC: 2835 In Vitro & In Vivo Diagnostic Substances